• 1
    Blum HE, Liang TJ, Galun E, Wands JR. Persistence of hepatitis B viral DNA after serological recovery from hepatitis B virus infection. Hepatology 1991; 14: 5663.
  • 2
    Chisari FV, Ferrari C. Hepatitis B virus immunopathogenesis. Annu Rev Immunol 1995; 13: 2960.
  • 3
    Bassendine MF, Della SL, Salmeron J, Thomas HC, Sherlock S. Incidence of hepatitis B virus infection in alcoholic liver disease, HBsAg negative chronic active liver disease and primary liver cell cancer in Britain. Liver 1983; 3: 6570.
  • 4
    Yokosuka O, Omata M, Imazeki F, Ito Y, Okuda K. Hepatitis B virus RNA transcripts and DNA in chronic liver disease. N Engl J Med 1986; 315: 11871192.
  • 5
    Fong TL, Govindarajan S, Valinluck B, Redeker AG. Status of hepatitis B virus DNA in alcoholic liver disease: a study of a large urban population in the United States. Hepatology 1988; 8: 16021604.
  • 6
    Brechot C, Degos F, Lugassy C, Thiers V, Zafrani S, Franco D, Bismuth H, et al. Hepatitis B virus DNA in patients with chronic liver disease and negative tests for hepatitis B surface antigen. N Engl J Med 1985; 312: 270276.
  • 7
    Zignego AL, Foschi M, Laffi G, Monti M, Careccia G, Romanelli RG, De ME, et al. “Inapparent” hepatitis B virus infection and hepatitis C virus replication in alcoholic subjects with and without liver disease. Hepatology 1994; 19: 577582.
  • 8
    Mendenhall CL, Seeff L, Diehl AM, Ghosn SJ, French SW, Gartside PS, Rouster SD, et al. Antibodies to hepatitis B virus and hepatitis C virus in alcoholic hepatitis and cirrhosis: their prevalence and clinical relevance. The VA Cooperative Study Group (No. 119). Hepatology 1991; 14: 581589.
  • 9
    Bellentani S, Tiribelli C, Saccoccio G, Sodde M, Fratti N, De MC, Cristianini G. Prevalence of chronic liver disease in the general population of northern Italy the Dionysos Study. Hepatology 1994; 20: 14421449.
  • 10
    Tang D, DeVit M, Johnston SA. Genetic immunization is a simple method for eliciting an immune response. Nature 1992; 356: 152154.
  • 11
    Wolff JA, Malone RW, Williams P, Chong W, Acsadi G, Jani A, Feigner PL. Direct gene transfer into mouse muscle in vivo. Science 1990: 14651468.
  • 12
    Blum HE, Galun E, Liang TJ, von Weizsacker F, Wands JR. Naturally occurring missense mutation in the polymerase gene terminating hepatitis B virus replication. J Virol 1991; 65: 18361842.
  • 13
    Heermann KH, Kruse F, Seifer M, Gerlich WH. Immunogenicity of the S and Pre-S gene domains in hepatitis B virions and HBsAg filaments. Intervirology 1987; 28: 1425.
  • 14
    Ben Porath E, Wands JR, Marciniak RA, Wong MA, Hornstein L, Ryder R, Canlas M, et al. Structural analysis of hepatitis B surface antigen by monoclonal antibodies. J Clin Invest 1985; 76: 13381347.
  • 15
    Mendenhall CL, Grossman CJ, Roselle GA, Ghosn S, Gartside PS, Rouster SD, Chalasani PV, et al. Host response to mycobacterial infection in the alcoholic rat. Gastroenterology 1990; 99: 17231726.
  • 16
    Milich DR, Hughes JL, McLachlan A, Langley KE, Thornton GB, Jones JE. Importance of subtype in the immune response to the pre-S(2) region of the hepatitis B surface antigen. I. T cell fine specificity. J Immunol 1990; 144: 35353543.
  • 17
    Milich DR, Hughes JL, McLachlan A, Thornton GB, Moriarty A. Hepatitis B synthetic immunogen comprised of nucleocapsid T-cell sites and an envelope B-cell epitope. Proc Natl Acad Sci U S A 1988; 85: 16101614.
  • 18
    Moriyama T, Guilhot S, Klopchin K, Moss B, Pinkert CA, Palmiter RD, Brinster RL, et al. Immunobiology and pathogenesis of hepatocellular injury in hepatitis B virus transgenic mice. Science 1990; 248: 361364.
  • 19
    Shirai M, Okada H, Nishioka M, Akatsuka T, Wychowski C, Houghten R, Pendleton CD, et al. An epitope in hepatitis C virus core region recognized by cytotoxic T cells in mice and humans. J Virol 1994; 68: 33343342.
  • 20
    von Weizsacker F, Maedi E, Brown NV, Poynard T, Galun E, Labeit S, Caput JC, et al. Hepatitis B and C virus infection in HBsAg-negative alcoholics without i. v. drug abuse or previous blood transfusions. International Hepatol Commun 1995; 4: 8087.
  • 21
    Tokushige KTW, Pachuk C, Moradpour D, Weiner D, Zurawski Jr VR, Wands JR. Expression and immune response to hepatitis C virus core DNA-based vaccine constructs. Hepatology 1996; 24: 1420.
  • 22
    Schirmbeck R, Bohm W, Ando K, Chisari FV, Reimann J. Nucleic acid vaccination primes hepatitis B virus surface antigen-specific cytotoxic T lymphocytes in nonresponder mice. J Virol 1995; 69: 59295934.
  • 23
    Geissler M, Tokushige K, Wands J. Cellular and humoral immune response to hepatitis B virus structural proteins in mice following DNA-based immunization. Gastroenterology 1997; 112: 13071320.
  • 24
    Lagging LM, Meyer K, Hoft D, Houghton M, Belshe RB, Ray R. Immune responses to plasmid DNA encoding the hepatitis C virus core protein. J Virol 1995; 69: 58595863.
  • 25
    Jayasinghe R, Gianutsos G, Hubbard AK. Ethanol-induced suppression of cell-mediated immunity in the mouse. Alcohol Clin Exp Res 1992; 16: 331335.
  • 26
    Jerrells TR, Saad AJ, Domiati SR. Effects of ethanol on parameters of cellular immunity and host defense mechanisms to infectious agents. Alcohol 1992; 9: 459463.
  • 27
    Chiappelli F, Kung M, Lee P, Pham L, Manfrini E, Villanueva P. Alcohol modulation of human normal T-cell activation, maturation, and migration. Alcohol Clin Exp Res 1995; 19: 539544.
  • 28
    Geissler M, Gesien A, Tokushige K, Wands JR. Enhancement of cellular and humoral immune responses to hepatitis C virus (HCV) core protein using DNA based vaccines augmented with cytokine expressing plasmids. J Immunol 1997; 158: 12311237.
  • 29
    Moran TM, Isobe H, Fernandez-Sesma A, Schulman JL. Interleukin-4 causes delayed virus clearance in influenza virus-infected mice. J Virol 1996; 70: 52305235.
  • 30
    Wang Y, Watson RR. Chronic ethanol consumption before retrovirus infection is a cofactor in the development of immune dysfunction during murine AIDS. Alcohol Clin Exp Res 1994; 18: 976981.
  • 31
    Wang Y, Huang DS, Giger PT, Watson RR. Influence of chronic dietary ethanol on cytokine production by murine splenocytes and thymocytes. Alcohol Clin Exp Res 1994; 18: 6470.
  • 32
    Wang Y, Watson RR. Chronic ethanol consumption prior to retrovirus infection alters cytokine production by thymocytes during murine AIDS. Alcohol 1994; 11: 361365.
  • 33
    Wagner F, Fink R, Hart R, Lersch C, Dancygier H, Classen M. Ethanol inhibits interferon-gamma secretion by human peripheral lymphocytes. J Stud Alcohol 1992; 53: 277280.
  • 34
    Bagasra O, Pomerantz RJ. Effects of acute ethanol infusion on susceptibility of peripheral blood mononuclear cells to infection with HIV-1 and on selected cytokine production in vitro. Natl Conf Hum Retroviruses Relat Infect (2nd) 1995; 2: 94.
  • 35
    Geissler M, Gesien A, Wands J. Cellular immune responses to HCV core protein are impaired by chronic ethanol consumption: immunologic mechanisms for the induction of persistent viral infection in alcoholics [Abstract]. 4th International Meeting on Hepatitis C Virus and Related Viruses: Molecular Virology and Pathogenensis, Kyoto, Japan. 1997: 212A.
  • 36
    Bagasra O, Howeedy A, Doric R, Kajdacsy BA. Functional analysis of T-cell subsets in chronic experimental alcoholism. Immunology 1987; 61: 6369.
  • 37
    Mendenhall C, Roselle GA, Lybecker LA, Marshall LE, Grossman CJ, Myre SA, Weesner RE, et al. Hepatitis B vaccination. Response of alcoholic with and without liver injury. Dig Dis Sci 1988; 33: 263269.
  • 38
    Villanueva C, Enriquez J, Just J, Teixido M, Mendez C, Rodrigo O. Vaccination against the hepatitis B virus in alcoholics. Med Clin (Bare) 1991; 96: 211214.
  • 39
    Pillot J, Poynard T, Elias A, Maillard J, Lazizi Y, Brancer M, Dubreuil P, et al. Weak immunogenicity of the preS2 sequence and lack of circumventing effect on the unresponsiveness to the hepatitis B virus vaccine. Vaccine 1995; 13: 289294.
  • 40
    Maruyama N, Sata M, Ishii K, Atono Y, Ono K, Matuda T, Suzuki H, et al. Hepatitis B vaccination in alcoholics. Kansenshogaku Zasshi 1989; 63: 2734.